CAPITOL COUNSEL LLC for BIOGEN, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare beneficiary access to treatments for Alzheimers disease, including Medicare Part B access issues, including related provisions in H.R. 5376, the Build Back Better Act, including Section 139001, Lowering Prices Through Drug Price Negotiation, and provisions regarding application of Maximum Fair Prices and Conforming Amendments to modify Medicare Part B reimbursement for selected drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAITLIN CANTER | — |
| JEFFREY CARROLL | — |
| AARON COHEN | — |
| SHANNON FINLEY | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
| JONATHAN KOTT | — |
Health Issues HCR
Patient access to treatments for Alzheimers disease, and 340B Drug Pricing Program related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAITLIN CANTER | — |
| JEFFREY CARROLL | — |
| AARON COHEN | — |
| SHANNON FINLEY | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
| JONATHAN KOTT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.